Sascha Tuchman, MD, MHS

Sascha Tuchman is Associate Professor and Director of the University of North Carolina Multiple Myeloma and Amyloidosis Program. He earned his medical degree from Georgetown University School of Medicine followed by internal medicine residency, chief residency, and hematology-medical oncology fellowship at Duke University.

Sascha Tuchman is an expert in managing patients with multiple myeloma, amyloidosis, and other plasma cell disorders. He has conducted NIH-supported lab research but now focuses on clinical research in treating multiple myeloma in patients who are at high risk for toxicity due to advanced age or other medical problems, developing novel drugs for treating all patients with multiple myeloma and optimizing management for amyloidosis.

Dr. Tuchman focuses his clinical practice and research efforts on multiple myeloma and amyloidosis of all subtypes. He has conducted NIH-funded research, participated in clinical trials, and authored multiple publications in these disorders.

Representative Publications:

Geriatric Assessment in Older Adults with Multiple Myeloma
A comparison of response in the presence or absence of a delay in induction therapy with bortezomib, lenalidomide, and dexamethasone
Undertreatment of Older Patients With Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies
Development of an Algorithm to Distinguish Smoldering Versus Symptomatic Multiple Myeloma in Claims-Based Data Sets
Efficacy and safety of high-dose chemotherapy with autologous stem cell transplantation in senior versus younger adults with newly diagnosed multiple myeloma